Hepcidin is a 25-aminoacid cysteine-rich iron regulating peptide. Hepcidin quantification in human blood may provide further insights for the pathogenesis of disorders of iron homeostasis and might prove a valuable tool for clinicians for the differential diagnosis of anaemia. This study describes ELISA immunoassay for hepcidin quantification in human serum. We used a sandwich ELISA method from USCN Life Science inc., that consists of ready to use, pre-coated 96-well strip plate with 2 antihepcidin-25 monoclonal antibodies. A recombinant hepcidin in 16 μg/l concentration is used as a standard; it reconstitutes with 1.0 ml standard diluent to prepare a stock solution. We correlated ELISA results of hepcidin-25 measurements in healthy population with hemodialysis patients. The sandwich ELISA was highly specific for hepcidin-25, having a low limit of quantification of 0.020 μg/l. Hepcidin- 25 concentrations were increased in hemodialysis patients (median 33.05 μg/l, range 22.31 -60.98 μg/l, n = 10) compared with healthy individuals (median 12.41 μg/l, range 6.05-18.53 μg/l, n = 40). The use of 2 monoclonal antibodies in a sandwich ELISA format provides a robust, convenient and not very expensive method for measuring concentrations of the active form of hepcidin. It should help to improve our understanding of the role of hepcidin in regulating iron metabolism.
1. Andrews , N. C. Anemia of infl ammation: the cytokine-hepcidin link. - J. Clin. Invest., 113, 2004, 1251-1253.
2. Anthony, M. et al. Dual-Monoclonal Sandwich ELISA Specifi c for Hepcidin-25. - Clin. Chem., 56, 2010, № 11, 1725-1732.
3. Ashby, D. R. et al. Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. - Haematologica, 95, 2010, 505-508.
4. Ashby, D. R. et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. - Kidney Int., 75, 2009, 976-981.
5. Busbridge , M. et al. Development of a novel immunoassay for the iron regulatory peptide hepcidin. - Br. J. Biomed. Sci., 66, 2009, 150-157.
6. De Domenico , I. et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. - Mol. Biol. Cell., 18, 2007, 2569-2578.
7. Donovan , A. et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. - Cell. Metab., 1, 2005, 191-200.
8. Fleming , R. E. et W. S. Sly. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. - Proc. Natl. Acad. Sci. USA, 98, 2001, 8160-8162.
9. Ganz , T. Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages. - Best Pract. Res. Clin. Haematol., 18, 2005, № 2, 171-182.
10. Koliaraki , V. et al. A novel immunological assay for hepcidin quantifi cation in human serum. - PLoS One, 4, 2009, e4581.
11. Krause , A. et al. LEAP-1, a novel highly disulfi de-bonded human peptide, exhibits antimicrobial activity. - FEBS Lett., 480, 2000, № 2-3, 147-150.
12. Kulaksiz , H., et al. Pro-hepcidin: expression and cell specifi c localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insuffi ciency, and renal anaemia. - Gut., 53, 2004, № 5, 735-743.
13. Luukkonen , S. et K. Punnonen. Serum pro-hepcidin concentrations and their responses to oral iron supplementation in healthy subjects manifest considerable inter-individual variation. - Clin. Chem. Lab. Med., 44, 2006, 1361-1362.
14. Malyszko , J. et M. Mysliwiec. Hepcidin in anemia and infl ammation in chronic kidney disease. - Kidney Blood Press. Res., 30, 2007, 15-30.
15. Nemeth , E. et al. (2004) IL-6 mediates hypoferremia of infl ammation by inducing the synthesis of the iron regulatory hormone hepcidin. - J. Clin. Invest., 113, 2004, № 9, 1271-1276.
16. Nemeth , E. et al. Hepcidin regulates cellular iron effl ux by binding to ferroportin and inducing its internalization. - Science, 306, 2004, № 5704, 2090-2093.
17. Park , C. H. et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. - J. Biol. Chem., 276, 2001, № 11, 7806-7810.
18. Pigeon , C. et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. - J. Biol. Chem., 276, 2001, 7811-7819.
19. Rivera , S. et al. Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia. - Blood, 105, 2005, 1797-802.
20. Roetto , A. et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. - Nat. Genet., 33, 2003, 21-22.
21. Taes , Y. E. et al. (2004) Prohepcidin accumulates in renal insuffi ciency. - Clin. Chem. Lab. Med., 42, 2004, № 4, 387-389.
22. Theur l , I. et al. Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. - Blood, 107, 2006, 4142-4148.
23. Valore , E. V. et T. Ganz. Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. - Blood Cells Mol. Dis., 40, 2008, № 1, 132-138.
24. Van der Putten , K. et al. Mechanisms of disease: erythropoietin resistance in patients with both heart and kidney failure. - Nat. Clin. Pract. Nephrol., 4, 2008, 47-57.
25. Koliaraki , V. et al. A Novel Immunological Assay for Hepcidin Quantifi cation in Human Serum. - PloS one, 4, 2009, № 2, e4581.
26. Weinstein , D. A. et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. - Blood, 100, 2002, 3776-3781.